Nortriptyline 10mg Film-coated Tablets

Land: Bretland

Tungumál: enska

Heimild: myHealthbox

Virkt innihaldsefni:

Nortriptyline Hydrochloride

Fáanlegur frá:

MEDREICH PLC

ATC númer:

N06AA10

INN (Alþjóðlegt nafn):

Nortriptyline Hydrochloride

Skammtar:

10mg

Lyfjaform:

Film-coated tablets

Stjórnsýsluleið:

Oral use

Einingar í pakka:

Blister pack sizes: 10 tablets, 30 tablets and 100 tablets.

Gerð lyfseðils:

POM - Prescription Only Medicine

Framleitt af:

MEDREICH PLC

Meðferðarhópur:

Antidepressant, tricyclic

Ábendingar:

indicated for the relief of symptoms of depression. It may also be used for the treatment of some cases of nocturnal enuresis.

Leyfisstaða:

Authorised

Leyfisdagur:

2015-03-26

Upplýsingar fylgiseðill

6-7
20-25 
44-55
10
8-11
25-35 
55-77
10-20
Over 11
35-54
77-119
25-35
AGE (YEARS)
WEIGHT
DOSE (MG)
KG
LB
years with psychiatric conditions who were treated with an 
antidepressant.
If you have thoughts of harming or killing yourself at any time, 
contact your doctor or go to hospital straight away.
You may find it helpful to tell a relative or close friend that you
are 
depressed or have an anxiety disorder, and ask them to read this 
leaflet. You
might ask them to tell you if they think your depression 
or anxiety is getting worse, or if they are worried about changes
in 
your behaviour.
If any of these points apply to you, tell your doctor or pharmacist.
TAKING OTHER MEDICINES
You should tell your doctor if you are taking or have taken any 
medicines, including medicines obtained without a prescription.
The following medicines may interact with your Nortriptyline Tablets:
•  guanethidine, debrisoquine, bethanidine, clonidine (used to
treat 
high blood pressure);
•  barbiturates (used for anxiety or to make you feel sleepy);
•  alcohol (you should not drink alcohol);
•  fluoxetine (another antidepressant);
•  cimetidine (for heartburn and ulcers);
•  phenothiazines (for mental illness);
•  carbamazepine (for epilepsy);
•  propafenone, flecainide, encainide, quinidine (for heartbeat
disorders)
It may still be all right for you to be given
Nortriptyline Tablets. 
Your doctor will be able to decide what is suitable for you.
DRIVING AND USING MACHINES
Nortriptyline Tablets may affect alertness. Use caution when 
driving or operating heavy machinery until you’re aware of how 
this drug affects you. If
you feel Nortriptyline Tablets affect your 
ability to drive or use machines, tell your doctor immediately.
IMPORTANT INFORMATION ABOUT SOME OF THE INGREDIENTS OF 
NORTRIPTYLINE TABLETS
Nortriptyline Tablets contain lactose. If you are
lactose intolerant, 
contact your doctor before taking this medicine. Nortriptylin

Vara einkenni

SUMMARY OF PRODUCT CHARACTERISTICS 

1 
NAME OF THE MEDICINAL PRODUCT 
Nortriptyline 10mg Film-coated Tablets 

2 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
Each film coated tablet contains Nortriptyline
Hydrochloride equivalent to 
Nortriptyline 10mg. 

Also contains lactose monohydrate and sunset yellow.  

For full list of excipients refer to section 6.1 

3 PHARMACEUTICAL 
FORM 
Film-coated Tablet 

Nortriptyline 10 mg Tablets are white to off coloured, round
biconvex, debossed with 
‘N’ on one side and 10 on other side. 

4 CLINICAL 
PARTICULARS 

4.1 THERAPEUTIC 
INDICATIONS 
Nortriptyline is indicated for the relief of symptoms of
depression. It may also be 
used 
for the treatment of some cases of nocturnal enuresis. 

4.2 
POSOLOGY AND METHOD OF ADMINISTRATION 
For oral administration. 

_Adults_: The usual adult dose is 25mg three or four times
daily. Dosage should begin 
at 
a low level and be increased as required.
Alternatively, the total daily dose may be 
given once a day. When doses above 100mg daily are administered,
plasma levels of 
Nortriptyline should be monitored and maintained in the
optimum range of 50 to 
150ng/ml. Doses above 150mg per day are not recommended. 

Lower than usual dosages are recommended for elderly patients and
adolescents. 
Lower dosages are also recommended for outpatients than for
hospitalised patients 
who will be
under close supervision. The physician should initiate dosage
at a low 
level and increase it gradually, noting carefully the
clinical response and any evidence 
of intolerance. Following remission, maintenance medication may be
required for a 
longer period of time at the lowest dose that
will maintain remission. 
If a patient develops minor side-effects, the dosage should
be reduced. The drug 
should be discontinued promptly if adverse effects of a serious
nature or all